The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Lipotoxic Diseases
Abstract
I review evidence that leptin is a liporegulatory hormone that controls lipid homeostasis in nonadipose tissues during periods of overnutrition. When adipocytes store excess calories as triacylglycerol (TG), leptin secretion rises so as to prevent accumulation of lipids in nonadipose tissues, which are not adapted for TG storage. Whenever leptin action is lacking, whether through leptin deficiency or leptin resistance, overnutrition causes disease of nonadipose tissues with generalized steatosis, lipotoxicity, and lipoapoptosis. Examples of such disorders of liporegulation include generalized lipodystrophies, mutations of leptin and leptin receptor genes, and diet-induced obesity. Lipotoxicity of pancreatic beta-cells, myocardium, and skeletal muscle leads, respectively, to type 2 diabetes, cardiomyopathy, and insulin resistance. In humans this constellation of abnormalities is referred to as the metabolic syndrome, a major health problem in the United States. When lipids overaccumulate in nonadipose tissues during overnutrition, fatty acids enter deleterious pathways such as ceramide production, which, through increased nitric oxide formation, causes apoptosis of lipid-laden cells, such as beta-cells and cardiomyocytes. Lipoapoptosis can be prevented by caloric restriction, by thiazolidinedione treatment, and by administration of nitric oxide blockers. There is now substantial evidence that complications of human obesity may reflect lipotoxicity similar to that described in rodents.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Steatosis occurs with decreased leptin action, whether due to leptin deficiency or resistance.9”
From Leptin reverses nonalcoholic steatohepatitis in patients with severe lipodystrophy† (2005) · cites this paper as [9]
Citations
Cites
Positional cloning of the mouse obese gene and its human homologue
Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., & Friedman, J. M. (1994) · Nature · doi:10.1038/372425a0 · Cited by 13,419
Weight-Reducing Effects of the Plasma Protein Encoded by the obese Gene
Halaas, J. L., Gajiwala, K. S., Maffei, M., Cohen, S. L., Chait, B. T., Rabinowitz, D., Lallone, R. L., Burley, S. K., & Friedman, J. M. (1995) · Science · doi:10.1126/science.7624777 · Cited by 4,451
Effects of the obese Gene Product on Body Weight Regulation in ob / ob Mice
Pelleymounter, M. A., Cullen, M. J., Baker, M. B., Hecht, R., Winters, D., Boone, T., & Collins, F. (1995) · Science · doi:10.1126/science.7624776 · Cited by 4,017
Campfield, L. A., Smith, F. J., Guisez, Y., Devos, R., & Burn, P. (1995) · Science · doi:10.1126/science.7624778 · Cited by 3,243
Congenital leptin deficiency is associated with severe early-onset obesity in humans
Montague, C. T., Farooqi, I. S., Whitehead, J. P., Soos, M. A., Rau, H., Wareham, N. J., Sewter, C. P., Digby, J. E., Mohammed, S. N., Hurst, J. A., et al. (1997) · Nature · doi:10.1038/43185 · Cited by 2,936
Obesity and the regulation of energy balance
Spiegelman, B. M., & Flier, J. S. (2001) · Cell · doi:10.1016/s0092-8674(01)00240-9 · Cited by 2,398
A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction
Clément, K., Vaisse, C., Lahlou, N., Cabrol, S., Pelloux, V., Cassuto, D., Gourmelen, M., Dina, C., Chambaz, J., Lacorte, J.-M., et al. (1998) · Nature · doi:10.1038/32911 · Cited by 2,346
Abnormal splicing of the leptin receptor in diabetic mice
Lee, G.-H., Proenca, R., Montez, J. M., Carroll, K. M., Darvishzadeh, J. G., Lee, J. I., & Friedman, J. M. (1996) · Nature · doi:10.1038/379632a0 · Cited by 2,327
Programmed Cell Death Induced by Ceramide
Obeid, L. M., Linardic, C. M., Karolak, L. A., & Hannun, Y. A. (1993) · Science · doi:10.1126/science.8456305 · Cited by 1,794
Adipose Tissue as an Endocrine Organ
Ahima, R. S., & Flier, J. S. (2000) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(00)00301-5 · Cited by 1,608
Cited by
Sorted by citations
Items 801–879 of 879
Thermogenesis and the Metabolic Syndrome
Bonet, M. L., Picó, C., & Palou, A. (2005) · Elsevier eBooks · doi:10.1016/b978-84-8174-892-5.50017-6 · Cited by 2
Role of PPARγ in adipocyte recruitment and thermogenesis
Nora, E. D., Gray, S. L., & Vidal‐Puig, A. (2007) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2.5.641 · Cited by 1
Obesity, Inflammation, Nonalcoholic Fatty Liver Disease, and Hepatocellular Carcinoma
Alkhouri, N., & McCullough, A. J. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6819-6_9 · Cited by 1
Lipidomics, Mass Spectrometry, and Bioinformatics
Hartler, J., Köfeler, H. C., Baker, C. J. O., Tharakan, R., & Thallinger, G. (2012) · Springer eBooks · doi:10.1007/978-3-7091-0947-2_6 · Cited by 1
Adipose Tissue Gene Expression in the Context of Inflammation and Obesity
Kern, P. A. (2006) · CRC Press eBooks · doi:10.1201/9781420005905.ch6 · Cited by 1
Atherogenic Dyslipoproteinemia in Type 2 Diabetes Mellitus
Arungovind, G., Kamalanathan, A. S., & Venkataraman, K. (2017) · Springer eBooks · doi:10.1007/978-3-319-60324-7_20 · Cited by 1
NON-ALCOHOLIC FATTY LIVER DISEASE -A NEW RISK FACTOR FOR THE DEVELOPMENT OF CHRONIC KIDNEY DISEASE
Стаценко, М. Е., Туркина, С. В., Ермоленко, А. А., Gorbacheva, E. E., & Sabanov, A. (2018) · Journal of Volgograd State Medical University · doi:10.19163/1994-9480-2018-2(66)-125-130 · Cited by 1
Special Issue: Islet Inflammation and Metabolic Homeostasis
Burke, S. J., & Collier, J. J. (2021) · Metabolites · doi:10.3390/metabo11020077 · Cited by 1
Gil, J. E. C., & Spinedi, E. (2017) · Revista Argentina de Endocrinología y Metabolismo · doi:10.1016/j.raem.2017.06.002 · Cited by 1
NAFLD, the hepatic manifestation of the metabolic syndrome
Chaudhury, T., Brodosi, L., Marchesini, G., Mitra, S. K., & Petroni, M. L. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-85732-1.00055-4 · Cited by 1
Drug Treatment in the Metabolic Syndrome
Karathanasis, S. K., & SCHIEBINGER, R. J. (2005) · Elsevier eBooks · doi:10.1016/b978-84-8174-892-5.50027-9 · Cited by 1
Metformin effects to carbohydrate and lipids metabolism in impaired glucose tolerance patients.
Dreval', A. V., Мисникова, И. В., Trigolosova, I. V., & Степановна, Т. Р. (2010) · Diabetes Mellitus · doi:10.14341/2072-0351-5676 · Cited by 1
Furuichi, Y. (2016) · Springer eBooks · doi:10.1007/978-4-431-55720-3_11 · Cited by 1
Obesity Heuristic, New Way on Artificial Immune Systems
El-dosuky, M. A. (2012) · Advanced Computing An International Journal · doi:10.5121/acij.2012.3601 · Cited by 2
Obesidade e doença renal: aspectos fisiopatológicos
Schelb, J. E., de Paula, R. D., Ezequiel, D. G. A., & Costa, M. B. (2019) · HU Revista · doi:10.34019/1982-8047.2018.v44.13982 · Cited by 2
Clavijo, A. ́. G., Maya, L. F. F., Muñoz-Loaiza, J. D., Perilla-Roa, D., Pérez-Moreno, E. J., Guzmán-Rojas, J. D. D., & Herrera-Cardona, J. E. (2020) · Revista de la Facultad de Medicina · doi:10.15446/revfacmed.v68n4.77325 · Cited by 1
Geneidy, A. A., & Solomon, R. (2006) · Humana Press eBooks · doi:10.1007/978-1-59259-985-1_18 · Cited by 1
Role of fatty liver in metabolic syndrome
Fodor, M. (2010) · Orvosi Hetilap · doi:10.1556/oh.2010.28897 · Cited by 1
New approach in the interpretation of the adipose tissue
Antal, M., & Regöly‐Mérei, A. (2010) · Orvosi Hetilap · doi:10.1556/oh.2010.28901 · Cited by 1
Type 2 diabetes: ceramides as a therapeutic target?
Hajduch, É., & Bourron, O. (2013) · Clinical Lipidology · doi:10.2217/clp.13.65 · Cited by 1
The Glitazones, Lessons so Far
Shirodkar, M., & Jabbour, S. A. (2007) · Springer eBooks · doi:10.1007/978-0-387-69737-6_10 · Cited by 1
Sensitization of Epithelial Cancer Cells with Human Monoclonal Antibodies
Vollmers, H. P., & Brändlein, S. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-474-2_1 · Cited by 1
Kushner, R. F., Lawrence, V., & FRCPath, S. K. M. F. (2013) · doi:10.1002/9781118643570.ch5
Obesity and Diabetes: Lipotoxicity
Lelliott, C. J., Orešič, M., & Vidal‐Puig, A. (2010) · Wiley eBooks · doi:10.1002/9783527629527.ch18
Development and Life Cycle of a β‐Cell
Serup, P., & Nielsen, J. H. (2003) · doi:10.1002/0470862092.d0201 · Cited by 1
The Endothelium, Cardiovascular Disease, and Therapy
Levine, T. B., & Levine, A. B. (2012) · Wiley eBooks · doi:10.1002/9781118480045.ch14
Biological Methods for Metabolic Research
Cebrián, A., Menchén, L., Sánchez‐López, E., Casado‐Vela, J., Díaz‐Moralli, S., Cascante, M., del Pulgar, T. G., & Lacal, J. C. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9780511996634.004
Dreval', A. V., Мисникова, И. В., & Trigolosova, I. V. (2010) · Obesity and metabolism · doi:10.14341/2071-8713-5277
New perspectives on childhood obesity
Fodor, M., & Sófi, G. (2013) · Orvosi Hetilap · doi:10.1556/oh.2013.29663
Kardiometabolische Protektion durch Reduktion von epikardialem Fettgewebe
Niemann, B., Li, L., Grieshaber, P., Dominik, E., Böning, A., & Rohrbach, S. (2015) · Zeitschrift für Herz- Thorax- und Gefäßchirurgie · doi:10.1007/s00398-015-0016-7
Ershova, E. V., Kolesnikova, G. S., & Butrova, S. A. (2004) · Obesity and metabolism · doi:10.14341/2071-8713-5178
Leptin secretion and severity of glycemic disorders in women with body weight excess
Dreval', A. V., Trigolosova, I. V., & Мисникова, И. В. (2013) · Diabetes Mellitus · doi:10.14341/2072-0351-3758
A leptina e o seu impacto metabólico nas lipodistrofias
Lau, E., Freitas, P., Isabel, O. A., & Carvalho, D. M. (2014) · Revista Portuguesa de Endocrinologia Diabetes e Metabolismo · doi:10.1016/j.rpedm.2014.03.003
Control of cellular lipid metabolism by fatty acid uptake – a novel concept
Glatz, J. F. C. (2004) · European Journal of Lipid Science and Technology · doi:10.1002/ejlt.200490051
Cardiovascular Disease and Hypertension in the Bariatric Surgery Patient
Edmundowicz, D. (2007) · Springer eBooks · doi:10.1007/978-0-387-68062-0_55
Uric Acid Nephrolithiasis: Basic and Clinical Aspects
Sakhaee, K. (2012) · Springer eBooks · doi:10.1007/978-1-4471-4387-1_18
Adipose Tissue Biology: An Update Review
Meiliana, A., & Wijaya, A. (2009) · The Indonesian Biomedical Journal · doi:10.18585/inabj.v1i3.98
Nutritional Strategies for Patients with Obesity and the Metabolic Syndrome
Kushner, R. F., & Roth, J. L. (2006) · Nutrition and disease prevention · doi:10.1201/9781420014884.ch4
Systems Biology Strategies in Studies of Energy Homeostasis In Vivo
Orešič, M., & Vidal‐Puig, A. (2009) · IGI Global eBooks · doi:10.4018/978-1-60566-076-9.ch021
Александровна, Л. Е., & Korchina, T. Y. (2016) · Экология человека · doi:10.33396/1728-0869-2016-12-49-53
Advanced Metabolomics for Metabolic Syndrome/Metabolic Diseases
Sun, X., & Zhu, J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-08-100596-5.22893-x
Obesity and NAFLD: Same Problem?
Brodosi, L., Barbanti, F. A., Petroni, M. L., Marchignoli, F., & Marchesini, G. (2020) · Springer eBooks · doi:10.1007/978-3-319-95828-6_1
Jadhav, S., & Радченко, В. Г. (2020) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-183-11-25-33
Ehasanbakhsh, H., Mirzaei, A., Bakhtiyari, S., Zavareh, M. S. A., & Jalilian, M. (2020) · Current Diabetes Reviews · doi:10.2174/1573399817666201228162950
Obesity and Non-Alcoholic Fatty Liver Disease: Pathophysiology and Management Focused
Febyan, F., & Weky, N. D. (2021) · European Journal of Medical and Health Sciences · doi:10.24018/ejmed.2021.3.1.645
Hidirova, L. D., Yakhontov, D. A., & Maksimov, V. N. (2021) · Terapevticheskii arkhiv · doi:10.26442/00403660.2021.01.200591
Relationship Between BMI Degree and Non-Alcoholic Fatty Liver Disease Risk Factors
Marpaung, C. F., Siregar, G. A., & Ilhamd (2021) · Journal of Endocrinology Tropical Medicine and Infectiouse Disease (JETROMI) · doi:10.32734/jetromi.v3i1.5593
Hormonal-immunologic status and peculiarities of nourishment in obese subjects
Александровна, Т. И., Petrov, I. M., Gagina, T. A., Медведева, И. В., & Maleyev, V. V. (2007) · Bulletin of Siberian Medicine · doi:10.20538/1682-0363-2007-1-97-104
A Case of Acute Pancreatic Necrosis in a Japanese Black Feedlot Cattle during Meat Inspection
KIMURA, K., & OHUCHI, S. (2021) · Journal of the Japan Veterinary Medical Association · doi:10.12935/jvma.74.197
Brain Insulin and Obesity: From Man to C. elegans
Porte, D. (2004) · Handbook of behavioral neurobiology · doi:10.1007/0-306-48643-1_7
(2009) · Wiley eBooks · doi:10.1002/9781444317176.refs
Leff, T., & Granneman, J. G. (2006) · Encyclopedia of Molecular Cell Biology and Molecular Medicine · doi:10.1002/3527600906.mcb.200300145
(2004) · Encyclopedic Dictionary of Genetics, Genomics and Proteomics · doi:10.1002/0471684228.egp08719
Yao, T., Wei, D., Tian, X., Zhao, L., Wan, Q., Zhang, X., Cai, J., Li, S., Diao, B., Feng, S., et al. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02069-1
Nguyen, Y. D. H., Pham, T. L. A., Nishihara, T., Kamei, K., & Bình, T. D. (2024) · Archives of Insect Biochemistry and Physiology · doi:10.1002/arch.22132
Cardiac lipotoxicity in diabetes and obesity
Iacobellis, G., & Canturk, A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-19116-9.00026-9
Yao, T., Wei, D., Tian, X., Zhao, L., Wan, Q., Zhang, X., Cai, J., Li, S., Diao, B., Feng, S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25449015
Omega-3 polyunsaturated fatty acids modulate sphingolipid metabolism in the hippocampus of aged rats
Hassouneh, L. K., Aldajah, S., Najdawi, M. M., Sirhan, A. Y., Abdullah, M., Altalhouni, A. A., & Abudayeh, Z. H. M. (2025) · Fìzìologìčnij žurnal · doi:10.15407/fz71.06.037
Detergents without a drain: the evolutionary logic (and liability) of sphingolipids
Summers, S. A. (2026) · Journal of Lipid Research · doi:10.1016/j.jlr.2026.100998
Insulin Resistance: Pathophysiology, Molecular Mechanisms, and Genetic Insights
Häring, H., & Gallwitz, B. (2026) · Elsevier eBooks · doi:10.1016/b978-0-323-87862-3.00002-1
Tissu adipeux ectopique et pathologie cardiaque
Gaborit, B. (2013) · theses.fr (ABES) · doi:10.70675/950549dfzb0e2z4faaz9e53z9e9fd1812f11
Étude du rôle des calpaïnes dans les complications microvasculaires du diabète
Salemkour, Y. (2023) · theses.fr (ABES) · doi:10.70675/36e8b2eezb42ez4ac4zac09z6f519c78839a
Sakhaee, K., & Moe, O. W. (2026) · Elsevier eBooks · doi:10.1016/b978-0-12-815389-5.00079-4
Balogh, T. S., Martins, D. J., Menck, C. F. M., Kadłubowski, S., & Lugão, A. B. (2026) · In vitro models · doi:10.1007/s44164-026-00115-z
Serum lipidome remodeling in viral pneumonia: from pathophysiology to therapeutics
Wang, Y., & Xiao, Q. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1836315 · Cited by 1
Understanding intrapancreatic fat: charting a path forward
Park, E., & Lee, P. J. (2026) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-026-01234-4
Obesity in Heart Failure: Mechanistic, Diagnostic and Therapeutic Considerations
Pathan, F. K., & Williams, K. (2026) · Cardiac failure review · doi:10.15420/cfr.2026.05
Rubio-Ruiz, M. E., Cano-Martínez, A., Méndez-Castro, J. A., Varona-Yañez, I. Y., Carreón‐Torres, E., Díaz‐Díaz, E., Ramos‐Godínez, M. D. P., Mendoza-Milla, C., & Cruz‐Gregorio, A. (2026) · Current Issues in Molecular Biology · doi:10.3390/cimb48090913
BindingDB (2016) · UC San Diego · doi:10.7270/q2f191hj
Metadata
- Authors
- Unger, R. H.
- Affiliations
- Dallas VA Medical Center (US)
- Corresponding author
- Unger, Roger H.
- Venue
- Annual Review of Medicine
- Publisher
- Annual Reviews
- Published
- 2002-02
- Volume
- 53
- Issue
- 1
- Pages
- 319-336
- ISSN
- 0066-4219 (ISSN-L)
- 1545-326X
- OpenAlex
- W4254261652
- Cited by
- 875
- References
- 71
- Citations by year
- 2026: 9 · 2025: 14 · 2024: 25 · 2023: 15 · 2022: 18 · 2021: 31 · 2020: 22 · 2019: 21 · 2018: 22 · 2017: 30 · 2016: 32 · 2015: 30 · 2014: 29 · 2013: 49 · 2012: 34
- FWCI
- 10.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annual Review of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Keywords
- leptin, lipotoxicity, lipid homeostasis, lipoapoptosis, leptin resistance, leptin deficiency, lipodystrophy, leptin receptor mutation, diet-induced obesity, type 2 diabetes, cardiomyopathy, insulin resistance, metabolic syndrome, ceramide, nitric oxide, caloric restriction, thiazolidinediones, obesity complications
- MeSH terms
- Adipose Tissue, Animals, Homeostasis, Humans, Lipids, Myocardium, Obesity, Risk Factors, Leptin, Metabolic Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review